A single nucleotide polymorphism rs9468925 of MHC region is associated with clinical features of generalized vitiligo in Chinese Han population

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 9, 2012, Pages 1137-1141

  Liu, Jianlan ^a   Tang, Huayang ^a   Zuo, Xianbo ^a   Liang, Bo ^a   Wang, Peiguang ^a   Sun, Liangdan ^a   Yang, Sen ^a   Zhang, Xuejun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA C ANTIGEN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HALO NEVUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHINA; ETHNIC GROUPS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; VITILIGO; YOUNG ADULT;

EID: 84865066338     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04259.x     Document Type: Article

References (20)

1. Guerra L, Dellambra E, Brescia S, et al. Vitiligo: pathogenetic hypotheses and targets for current therapies. Curr Drug Metab 2010; 11: 451-467.
2. Alkhateeb A, Qarqaz F, Al-Sabah J, et al. Clinical characteristics and PTPN22 1858C/Tvariant analysis in Jordanian Arab vitiligo patients. Mol Diagn Ther 2010; 14: 179-184.
3. Das SK, Majumder PP, Chakraborty R, et al. Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol 1985; 2: 71-78.
4. Birlea SA, Fain PR, Spritz RA,. A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases. Arch Dermatol 2008; 144: 310-316.
5. Taieb A, Picardo M,. Clinical practice. Vitiligo. N Engl J Med 2009; 360: 160-169.
6. Hann SK, Nordlund JJ,. Clinical features of generalized vitiligo. In:, Hann SK, Nordlund JJ, eds. Vitiligo. Oxford, Blackwell Science, 2000: 35-48.
7. Zhang XJ, Liu JB, Gui JP, et al. Characteristics of genetic epidemiology and genetic models for vitiligo. J Am Acad Dermatol 2004; 51: 383-390.
8. Alkhateeb A, Fain PR, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003; 16: 208-214.
9. Quan C, Ren YQ, Xiang LH, et al. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet 2010; 42: 614-618.
10. Taieb A, Picardo M,. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007; 20: 27-35.
11. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
12. Finco O, Cuccia M, Martinetti M, et al. Age of onset in vitiligo: relationship with HLA supratypes. Clin Genet 1991; 39: 48-54.
13. Dunston GM, Halder RM,. Vitiligo is associated with HLA-DR4 in black patients. A preliminary report. Arch Dermatol 1990; 126: 56-60.
14. Laberge G, Mailloux CM, Gowan K, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 2005; 18: 300-305.
15. Xia Q, Zhou WM, Liang YH, et al. MHC haplotypic association in Chinese Han patients with vitiligo. J Eur Acad Dermatol Venereol 2006; 20: 941-946.
16. Fain PR, Babu SR, Bennett DC, et al. HLA class II haplotype DRB104-DQB10301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Res 2006; 19: 51-57.
17. Macaron C, Winter RJ, Traisman HS, et al. Vitiligo and juvenile diabetes mellitus. Arch Dermatol 1977; 113: 1515-1517.
18. Brazzelli V, Quaglini M, Martinetti M, et al. A peculiar sequence motif in the alpha-1-domain of the HLA-C molecule in psoriasis. Dermatology 2000; 200: 99-103.
19. Das PK, van den Wijngaard RM, Wankowicz-Kalinska A, et al. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends Immunol 2001; 22: 130-136.
20. de Vijlder HC, Westerhof W, Schreuder GM, et al. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res 2004; 17: 270-274.